Cyclosporine C 2 monitoring is superior to C 0 in predicting acute cellular rejection in heart transplant recipients in Taiwan

N. K. Chou, R. J. Chen, W. J. Ko, H. L. Lin, S. Y. Yu, Y. S. Chen, R. B. Hsu, C. M. Lee, F. Y. Lin, S. S. Wang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The cyclosporine (CsA) blood concentration at 2 hours postdose (C 2) has been shown to be better than trough level (C 0) to predict acute cellular rejection (ACR) in solid organ transplantations. We tried to assess the superiority of C 2 monitoring to C 0 in heart transplantation (HTx). Prospective data were collected from the HTx recipients from November 1991 to April 2003. The 100 patients surviving longer than 3 months after HTx, provided 237 sample sets, with ACR graded by endomyocardial biopsy (EMB) and concurrent C 0 and C 2 levels. ACR was defined as International Society of Heart and Lung Transplantation (ISHLT) grade lb or higher. Nonparametric methods, logistic regression model, and receiver operating characteristic (ROC) analysis were used. There was no significant demographic heterogeneity between ACR and non-ACR groups. C 2 was significantly lower in ACR than non-ACR groups (P =. 0192) whereas C 0 showed no significant difference. In the logistic regression model, C 2 was a significant predictor against ACR (P =. 026, odds ratio = 0.76 per 100 ng/mL), but C 0 was not. ROC analysis showed that C 2 of 600 ng/mL might provide the optimal cut-off point, with a sensitivity of 51.23% and a specificity of 71.43%, but C 0 did not show this association. In conclusion, C 2 monitoring is superior to C 0 for predicting ACR in HTx. ACR should be suspected when the C 2 value is below 600 ng/mL.

Original languageEnglish
Pages (from-to)2393-2395
Number of pages3
JournalTransplantation Proceedings
Volume36
Issue number8
DOIs
Publication statusPublished - Oct 1 2004
Externally publishedYes

Fingerprint

Taiwan
Cyclosporine
Logistic Models
ROC Curve
Heart-Lung Transplantation
Organ Transplantation
Heart Transplantation
Odds Ratio
Demography
Biopsy
Transplant Recipients

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Cyclosporine C 2 monitoring is superior to C 0 in predicting acute cellular rejection in heart transplant recipients in Taiwan. / Chou, N. K.; Chen, R. J.; Ko, W. J.; Lin, H. L.; Yu, S. Y.; Chen, Y. S.; Hsu, R. B.; Lee, C. M.; Lin, F. Y.; Wang, S. S.

In: Transplantation Proceedings, Vol. 36, No. 8, 01.10.2004, p. 2393-2395.

Research output: Contribution to journalArticle

Chou, N. K. ; Chen, R. J. ; Ko, W. J. ; Lin, H. L. ; Yu, S. Y. ; Chen, Y. S. ; Hsu, R. B. ; Lee, C. M. ; Lin, F. Y. ; Wang, S. S. / Cyclosporine C 2 monitoring is superior to C 0 in predicting acute cellular rejection in heart transplant recipients in Taiwan. In: Transplantation Proceedings. 2004 ; Vol. 36, No. 8. pp. 2393-2395.
@article{966a337c8b7c41fd945dad7ea2caddf5,
title = "Cyclosporine C 2 monitoring is superior to C 0 in predicting acute cellular rejection in heart transplant recipients in Taiwan",
abstract = "The cyclosporine (CsA) blood concentration at 2 hours postdose (C 2) has been shown to be better than trough level (C 0) to predict acute cellular rejection (ACR) in solid organ transplantations. We tried to assess the superiority of C 2 monitoring to C 0 in heart transplantation (HTx). Prospective data were collected from the HTx recipients from November 1991 to April 2003. The 100 patients surviving longer than 3 months after HTx, provided 237 sample sets, with ACR graded by endomyocardial biopsy (EMB) and concurrent C 0 and C 2 levels. ACR was defined as International Society of Heart and Lung Transplantation (ISHLT) grade lb or higher. Nonparametric methods, logistic regression model, and receiver operating characteristic (ROC) analysis were used. There was no significant demographic heterogeneity between ACR and non-ACR groups. C 2 was significantly lower in ACR than non-ACR groups (P =. 0192) whereas C 0 showed no significant difference. In the logistic regression model, C 2 was a significant predictor against ACR (P =. 026, odds ratio = 0.76 per 100 ng/mL), but C 0 was not. ROC analysis showed that C 2 of 600 ng/mL might provide the optimal cut-off point, with a sensitivity of 51.23{\%} and a specificity of 71.43{\%}, but C 0 did not show this association. In conclusion, C 2 monitoring is superior to C 0 for predicting ACR in HTx. ACR should be suspected when the C 2 value is below 600 ng/mL.",
author = "Chou, {N. K.} and Chen, {R. J.} and Ko, {W. J.} and Lin, {H. L.} and Yu, {S. Y.} and Chen, {Y. S.} and Hsu, {R. B.} and Lee, {C. M.} and Lin, {F. Y.} and Wang, {S. S.}",
year = "2004",
month = "10",
day = "1",
doi = "10.1016/j.transproceed.2004.08.115",
language = "English",
volume = "36",
pages = "2393--2395",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Cyclosporine C 2 monitoring is superior to C 0 in predicting acute cellular rejection in heart transplant recipients in Taiwan

AU - Chou, N. K.

AU - Chen, R. J.

AU - Ko, W. J.

AU - Lin, H. L.

AU - Yu, S. Y.

AU - Chen, Y. S.

AU - Hsu, R. B.

AU - Lee, C. M.

AU - Lin, F. Y.

AU - Wang, S. S.

PY - 2004/10/1

Y1 - 2004/10/1

N2 - The cyclosporine (CsA) blood concentration at 2 hours postdose (C 2) has been shown to be better than trough level (C 0) to predict acute cellular rejection (ACR) in solid organ transplantations. We tried to assess the superiority of C 2 monitoring to C 0 in heart transplantation (HTx). Prospective data were collected from the HTx recipients from November 1991 to April 2003. The 100 patients surviving longer than 3 months after HTx, provided 237 sample sets, with ACR graded by endomyocardial biopsy (EMB) and concurrent C 0 and C 2 levels. ACR was defined as International Society of Heart and Lung Transplantation (ISHLT) grade lb or higher. Nonparametric methods, logistic regression model, and receiver operating characteristic (ROC) analysis were used. There was no significant demographic heterogeneity between ACR and non-ACR groups. C 2 was significantly lower in ACR than non-ACR groups (P =. 0192) whereas C 0 showed no significant difference. In the logistic regression model, C 2 was a significant predictor against ACR (P =. 026, odds ratio = 0.76 per 100 ng/mL), but C 0 was not. ROC analysis showed that C 2 of 600 ng/mL might provide the optimal cut-off point, with a sensitivity of 51.23% and a specificity of 71.43%, but C 0 did not show this association. In conclusion, C 2 monitoring is superior to C 0 for predicting ACR in HTx. ACR should be suspected when the C 2 value is below 600 ng/mL.

AB - The cyclosporine (CsA) blood concentration at 2 hours postdose (C 2) has been shown to be better than trough level (C 0) to predict acute cellular rejection (ACR) in solid organ transplantations. We tried to assess the superiority of C 2 monitoring to C 0 in heart transplantation (HTx). Prospective data were collected from the HTx recipients from November 1991 to April 2003. The 100 patients surviving longer than 3 months after HTx, provided 237 sample sets, with ACR graded by endomyocardial biopsy (EMB) and concurrent C 0 and C 2 levels. ACR was defined as International Society of Heart and Lung Transplantation (ISHLT) grade lb or higher. Nonparametric methods, logistic regression model, and receiver operating characteristic (ROC) analysis were used. There was no significant demographic heterogeneity between ACR and non-ACR groups. C 2 was significantly lower in ACR than non-ACR groups (P =. 0192) whereas C 0 showed no significant difference. In the logistic regression model, C 2 was a significant predictor against ACR (P =. 026, odds ratio = 0.76 per 100 ng/mL), but C 0 was not. ROC analysis showed that C 2 of 600 ng/mL might provide the optimal cut-off point, with a sensitivity of 51.23% and a specificity of 71.43%, but C 0 did not show this association. In conclusion, C 2 monitoring is superior to C 0 for predicting ACR in HTx. ACR should be suspected when the C 2 value is below 600 ng/mL.

UR - http://www.scopus.com/inward/record.url?scp=9244219597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9244219597&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2004.08.115

DO - 10.1016/j.transproceed.2004.08.115

M3 - Article

C2 - 15561260

AN - SCOPUS:9244219597

VL - 36

SP - 2393

EP - 2395

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 8

ER -